Medium-Term Effects of Bisoprolol Administration on Renal Hemodynamics and Function in Mild to Moderate Essential Hypertension

Risultato della ricerca: Article

6 Citazioni (Scopus)

Abstract

Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. β-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the β 1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension.
Lingua originaleEnglish
pagine (da-a)1260-1270
Numero di pagine11
RivistaAdvances in Therapy
Volume24
Stato di pubblicazionePublished - 2007

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cita questo

@article{451fc380a5764b0e90730e713e3831f5,
title = "Medium-Term Effects of Bisoprolol Administration on Renal Hemodynamics and Function in Mild to Moderate Essential Hypertension",
abstract = "Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. β-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the β 1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension.",
author = "Silvio Fasullo and Giuseppe Licata and Salvatore Paterna and Antonina Tarantino and Gaspare Parrinello and Daniele Torres and Ersilia Fornaciari and Roberta Antona and Salvatore Paterna and {Di Pasquale}, Pietro and Sergio Fasullo and Daniele Torres",
year = "2007",
language = "English",
volume = "24",
pages = "1260--1270",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",

}

TY - JOUR

T1 - Medium-Term Effects of Bisoprolol Administration on Renal Hemodynamics and Function in Mild to Moderate Essential Hypertension

AU - Fasullo, Silvio

AU - Licata, Giuseppe

AU - Paterna, Salvatore

AU - Tarantino, Antonina

AU - Parrinello, Gaspare

AU - Torres, Daniele

AU - Fornaciari, Ersilia

AU - Antona, Roberta

AU - Paterna, Salvatore

AU - Di Pasquale, Pietro

AU - Fasullo, Sergio

AU - Torres, Daniele

PY - 2007

Y1 - 2007

N2 - Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. β-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the β 1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension.

AB - Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. β-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the β 1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension.

UR - http://hdl.handle.net/10447/3579

M3 - Article

VL - 24

SP - 1260

EP - 1270

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

ER -